Target intelligence / Profile preview

Candida cell wall epitopes and virulence-associated proteins

Molecular classification
Polysaccharide, Enzyme, Glycoprotein, Adhesin, Virulence factor
01

Overview

Candida cell wall epitopes and virulence-associated proteins encompass a broad array of structural and functional molecules essential for the pathogenicity of Candida species, most notably Candida albicans. The fungal cell wall is a dynamic, multilayered structure consisting of an inner core of chitin and beta-glucans, and an outer layer of mannosylated proteins (mannoproteins) [8, 11]. These components are critical for maintaining cell integrity, mediating adhesion to host tissues (e.g., Als3, Hwp1), and facilitating invasion through the secretion of hydrolases like secreted aspartyl proteases (Saps) [4, 10]. Because these molecules are absent in humans and are surface-exposed, they serve as primary targets for the host immune system and therapeutic interventions [2, 6]. Current treatments include echinocandins, which inhibit beta-glucan synthesis, while emerging strategies focus on vaccines (e.g., NDV-3A) and monoclonal antibodies designed to neutralize virulence factors or enhance opsonization [1, 3, 7]. Targeting these epitopes is particularly relevant for addressing multidrug-resistant pathogens like Candida auris, where traditional antifungals may fail [2, 12].

Other names
Candida cell wall antigensCandida virulence factorsFungal cell wall proteinsCandida cell surface epitopesCandida albicans cell wall proteins
02

Mechanism of action

Inhibition of beta-1,3-glucan synthase; Inhibition of Gwt1 protein (GPI-anchor synthesis); Neutralization of virulence factors; Opsonization and enhancement of phagocytosis; Inhibition of secreted aspartyl proteases

03

Biological functions

Cell wall organizationAdhesionBiofilm formationImmune evasionProteolysisIron acquisitionInvasion
04

Disease associations

Infection
05

Safety considerations

Development of antifungal resistance (e.g., FKS mutations)Infusion-related reactionsPotential for cross-reactivity with host glycans (rare)Hepatotoxicity
06

Interacting drugs

Caspofungin

8 more in the full profile.

07

Biomarkers

(1,3)-beta-D-glucan (BDG)Mannan antigenAnti-mannan antibodies

Beyond the preview

Go deeper on Candida cell wall epitopes and virulence-associated proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Candida cell wall epitopes and virulence-associated proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call